J. Kalra

发表

Using Pharmacokinetic Profiles and Digital Quantification of Stained Tissue Microarrays as a Medium-Throughput, Quantitative Method for Measuring the Kinetics of Early Signaling Changes Following Integrin-Linked Kinase Inhibition in an In Vivo Model of Cancer

W. Dragowska, M. Bally, J. Kalra, 2015, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1

K. Gelmon, S. Dedhar, S. Dunn, 2010, Oncogene.

Applications for Drug Development

M. Bally, M. Webb, D. Yapp, 2016, Handbook of Small Animal Imaging.

Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism.

D. Laird, Qing Shao, M. Alaoui-Jamali, 2006, Carcinogenesis.

QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model

K. Gelmon, S. Dedhar, M. Bally, 2009, Breast Cancer Research.

Connexin26 Regulates the Expression of Angiogenesis-Related Genes in Human Breast Tumor Cells by Both GJIC-Dependent and -Independent Mechanisms

D. Laird, Qing Shao, M. Alaoui-Jamali, 2003, Cell communication & adhesion.

Harnessing the potential of lipid-based nanomedicines for type-specific ovarian cancer treatments.

M. Anglesio, M. Bally, N. Santos, 2014, Nanomedicine.

Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of Integrin-linked kinase (ILK)

D. Huntsman, S. Dedhar, M. Bally, 2008, Molecular Cancer Therapeutics.

Inter-Metastatic Heterogeneity of Tumor Marker Expression and Microenvironment Architecture in a Preclinical Cancer Model

M. Bally, A. Minchinton, A. Kyle, 2021, International journal of molecular sciences.

Using Digital Quantification of Stained Tissue Microarrays as a Medium-Throughput, Quantitative Method for Measuring the Kinetics of Signal Transduction.

Jessica Kalra, Jennifer Baker, J. Baker, 2017, Methods in molecular biology.

Integrin Linked Kinase as a therapeutic target for treating breast cancer : the value of using multiple endpoints to assess therapeutic effects of targeted drugs and drug combinations

J. Kalra, 2010 .

Determination of an optimal dosing schedule for combining Irinophore C™ and temozolomide in an orthotopic model of glioblastoma.

M. Bally, M. Verreault, M. Wehbe, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Breast Cancer Therapies Present and Future

L. Edwards, J. Kalra, 2012 .

5′-AMP-activated Protein Kinase (AMPK) Supports the Growth of Aggressive Experimental Human Breast Cancer Tumors*

L. Boros, N. Denko, K. Laderoute, 2014, The Journal of Biological Chemistry.

Multiplex Immunohistochemistry for Mapping the Tumor Microenvironment.

Jessica Kalra, Jennifer Baker, J. Baker, 2017, Methods in molecular biology.

Bioluminescence Applications in Preclinical Oncology Research

M. Bally, J. Kalra, 2012 .

7 Bioluminescence Applications in Preclinical Oncology Research

M. Bally, J. Kalra, 2017 .